Supplemental Oxygen: Clinical Trials

4 trials of Supplemental Oxygen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 withdrawn. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Withdrawn 1

Follow Supplemental Oxygen: new trials by email Literature Review of Supplemental Oxygen trials Research Report on Supplemental Oxygen

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use.
Sham Air, Supplemental Oxygen - Sleep-disordered Breathing, Chronic Opioid Use
Phase 2Not yet recruitingUniversity of California, San Diego622026-12-012026-11-06
Do Endotypes Predict Response and Sequelae in OSA Patients
Eszopiclone, Supplemental Oxygen, Continuous Positive Airway Pressure (CPAP) - Obstructive Sleep Apnea, Sleep Apnea
Phase 2CompletedUniversity of California, San Diego2332020-08-012026-06-18
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Abciximab, Placebo, Intravenous hydration - Sickle Cell Disease, Hb-SS Disease With Vasoocclusive Pain
Phase 2WithdrawnSt. Louis University2013-11-012015-03-26
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
acetazolamide, Supplemental oxygen, Non-invasive ventilation - Pulmonary Hypertension, Breathing-Related Sleep Disorder
Phase 2CompletedUniversity of Zurich232010-11-012012-12-12

Conditions studied

Sleep Apnea Syndromes (2)  ·  Sleep Apnea, Obstructive (2)  ·  Anemia, Sickle Cell (1)  ·  Hypertension, Pulmonary (1)  ·  Microcephaly, Primary Autosomal Recessive, 6 (1)  ·  Sleep Apnea, Central (1)  ·  Sleep Wake Disorders (1)  ·  Vaso-Occlusive Crises (1)

Sponsors

University of California, San Diego (2)  ·  St. Louis University (1)  ·  University of Zurich (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Atul Malhotra, MD (1)  ·  Christopher Schmickl (1)  ·  Jeremy Orr, MD (1)  ·  William S Ferguson, MD (1)

Results publications

PMID 24366914, PMID 24991933

NIH funding

R01HL179220 (1)